XM does not provide services to residents of the United States of America.
A
A

AuroraCannabis

News

Pot stocks fall as US drug agency to hold reclassification hearing after elections

BUZZ-Pot stocks fall as US drug agency to hold reclassification hearing after elections ** U.S.-listed shares of cannabis firms fall in premarket trade ** Shares slide as Drug Enforcement Administration said hearing on the proposal to reclassify marijuana to a Schedule III drug will take place on Dec. 2, after the U.S. presidential elections ** SND
A
C
C

Canopy Growth posts smaller-than-expected core loss as costs drop

Canopy Growth posts smaller-than-expected core loss as costs drop Aug 8 (Reuters) - Canadian pot firm Canopy Growth WEED.TO reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis. Its U.S.-listed shares CGC.O were up 3.3% at $7.15 in premarket trading.
A
C

Aurora Cannabis Inc reports results for the quarter ended in June - Earnings Summary

Aurora Cannabis Inc reports results for the quarter ended in June - Earnings Summary Aurora Cannabis Inc ACB.TO reported quarterly adjusted earnings of 13 cents​​ per share for the quarter ended in June. The lone analyst forecast for the quarter was for a loss of 48 cents per share. Revenue was C$83.44 million​; analysts expected C$78.00 million.
A

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Aurora Cannabis rises on strong Q1 results

BUZZ-Aurora Cannabis rises on strong Q1 results ** U.S.-listed shares of pot firm Aurora Cannabis ACB.TO , ACB.O up 11.4% at $6.55 premarket ** Co reports positive first-quarter free cash flow (FCF) of C$6.5 mln vs negative FCF of C$11.7 mln a year ago ** Quarterly revenue was up 11.6% at C$83.4 mln from prior year, beating estimates of C$77.2 mln
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.